本页面由Tiger Trade Technology Pte. Ltd.提供服务

Ionis Pharmaceuticals, Inc

42.38
-1.2900-2.95%
盘后:42.890.5100+1.20%16:07 EDT
成交量:297.73万
成交额:1.27亿
市值:70.43亿
市盈率:-12.18
高:43.58
开:43.55
低:42.36
收:43.67
52周最高:86.74
52周最低:42.36
股本:1.66亿
流通股本:1.62亿
量比:0.97
换手率:1.84%
股息:- -
股息率:- -
每股收益(TTM):-3.4800
每股收益(LYR):-2.3812
净资产收益率:-105.50%
总资产收益率:-12.42%
市净率:16.02
市盈率(LYR):-17.80

数据加载中...

2026/06/08

重要事件披露

Form 8-K - Current report
2026/06/01

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/28

重要事件披露

Form 8-K - Current report
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/15

超过5%披露

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2026/05/13

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/05/04

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/30

超过5%披露

Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors
2026/04/29

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2026/04/29

重要事件披露

Form 8-K - Current report
2026/04/28

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/21

重要事件披露

Form 8-K - Current report
2026/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/04/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/31

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/19

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/16

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/11

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2026/03/10

关联方拟减持公告

Form 144 - Report of proposed sale of securities